Mohammed Al Azzawi

Mohammed Al Azzawi

Auto-generated profile, based on publicly available information

Mohammed Al Azzawi

Irish Surgical Research Collaborative, Royal College of Surgeons in Ireland, Dublin, Ireland

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2021 in European Journal of Surgical Oncology
Verified
Journal Article
Open access
JBJarlath Bolger
Jarlath Bolger
MAMohammed Al Azzawi
Mohammed Al Azzawi
JWJack Whooley
Jack Whooley
EBEamonn M. Bolger
Eamonn M. Bolger
LTLuke Trench
Luke Trench
WRWilliam B. Robb
William B. Robb
Textbook outcome (TBO) is a composite measure of a number of peri-operative and clinical outcomes in oesophagogastric malignancy. It has previously been shown that TBOs are associated with improved overall survival in both oesophageal and gastric cancer. The influence of a minimally invasive approach (MIA) on TBO is not well defined. The purpose of this study is to validate TBO in our population, examine the influence of a MIA on achieving a TBO, and the impact of TBO on long-term survival. 269 patients undergoing oesophagectomy and 258 patients undergoing subtotal or total gastrectomy were included in this study. Demographic, clinical and pathological differences between patients with and without a TBO were compared using univariable and multivariable analysis. Overall survival for those with and without a TBO was examined. The influence of MIA on overall survival and TBO was determined using Cox proportional hazard models. Patients undergoing oesophagectomy and gastrectomy were significantly more likely to achieve a TBO when MIA was used (p = 0.01 and 0.001 respectively). When MIA is included as an outcome measure patients achieving a TBO show improved overall survival in both oesophageal and gastric cancer. MIA, clear resection margins and no unplanned admission to critical care are the strongest predictors of overall survival from the putative bundle of TBO parameters. Minimally invasive surgery is associated with improved TBO. Completion of a minimally invasive approach should be considered for inclusion as a textbook parameter.

11 October 2024 in The Surgeon
Verified
Journal Article
Closed access
CCC. Cullinane
C. Cullinane
AEA. Edwards-Murphy
A. Edwards-Murphy
CKC. Kennedy
C. Kennedy
CTC. Toale
C. Toale
MAM. Al Azzawi
M. Al Azzawi
CFC. Fleming
C. Fleming

21 July 2026 in Obesity Surgery
Verified
Journal Article
Open access
PDF file
CKCzara Kennedy
Czara Kennedy
MAMohammed Al Azzawi
Mohammed Al Azzawi
MDMatthew Davey
Matthew Davey
JCJulie Therese Clifford
Julie Therese Clifford
WBWaqas Butt
Waqas Butt
HHHelen Heneghan
Helen Heneghan
Introduction: Venous thromboembolism (VTE) remains a leading cause of preventable morbidity and mortality following metabolic bariatric surgery (MBS). Low-molecular-weight heparin (LMWH) is widely used for thromboprophylaxis; however, the optimal prophylactic enoxaparin dose in patients with obesity remains uncertain. Anti-factor Xa (anti-Xa) activity is commonly used as a surrogate marker of pharmacological efficacy. Methods: A systematic review and meta-analysis was conducted in accordance with PRISMA guidelines and registered with PROSPERO. PubMed, EMBASE, the Cochrane Library, and ClinicalTrials.gov were searched from inception to 31 March 2026. Studies evaluating prophylactic enoxaparin dosing in patients with obesity undergoing MBS, with reported anti-Xa levels, were included. Random-effects meta-analyses compared lower (30–40 mg) versus higher (60 mg) enoxaparin regimens with respect to attainment of prophylactic anti-Xa levels with secondary outcomes including mean anti-Xa activity, VTE and bleeding event rates. Results: Ten studies comprising 1,069 enrolled patients, of whom 1,016 contributed to the primary meta-analysis, met the inclusion criteria. There was no significant difference in the proportion of patients achieving prophylactic anti-Xa levels between higher and lower dose regimens (risk ratio 1.05, 95% CI 0.91–1.20; I² = 58.2%, p = 0.0104). Higher doses were associated with significantly increased mean anti-Xa levels (mean difference 0.13 IU/mL, 95% CI 0.05–0.21; p = 0.001). Conclusion: Higher prophylactic enoxaparin doses increase anti-Xa levels but do not improve attainment of prophylactic targets compared with standard dosing following MBS. In a post-hoc, exploratory, hypothesis-generating subgroup analysis, BMI-adjusted dosing strategies demonstrated comparable pharmacodynamic efficacy to fixed higher doses; this finding is not pre-specified and should not be used to support definitive conclusions. High-quality multicentre randomised trials are required to define optimal thromboprophylaxis strategies in this high-risk population.

1 March 2021 in British Journal of Surgery
Verified
Journal Article
Open access
PDF file
MAM Al Azzawi
M Al Azzawi
JBJc Bolger
Jc Bolger
EBEm Bolger
Em Bolger
JWJ Whooley
J Whooley
JAJ Allen
J Allen
WRWb Robb
Wb Robb
Introduction: High quality surgery remains the cornerstone of treating oesophago-gastric malignancy. Recent work from the Dutch Upper-gastrointestinal Cancer Audit (DUCA) have defined ten surgical and perioperative ‘textbook’ parameters that correlate with improved overall survival. The aim of this project was to examine the proportion of patients attaining ‘textbook’ outcomes for oesophagectomy and gastrectomy in our unit before and after the introduction of national key performance indicators (KPIs). Method: A retrospective review of all oesophagectomies and gastrectomies from January 2010 until June 2019 was performed. Clinical, pathological, perioperative, morbidity and mortality outcomes were recorded. 10 ‘textbook’ parameters were studied pre- and post-KPI introduction. Result: 269 and 284 patients underwent oesophagectomy and gastrectomy respectively, 167 pre-KPI and 386 post-KPI. There were no significant differences in age (67.6 vs 66.4 years, p=0.6), gender (71% male, 29% female vs 68% male, 22% female, p=0.48), ASA grade (p=0.6) or tumour stage (p=0.37) pre- and post-KPI. In the pre-KPI era, 28/167 (17%) patients achieved all ten textbook parameters, compared with 157/386, (41%, p=0.001) post-KPI. This compares favourably to DUCA ‘textbook’ data. There was an improvement in adequate lymphadenectomy (56% vs 83%, p=0.002), a reduction in margin positivity (21% vs 7%, p= 0.001) and peri-operative mortality (6% vs 2%, p=0.03) post-KPI. Conclusion: There has been a significant improvement in perioperative outcomes in esophagectomy following the introduction of national KPIs in our unit. The number of patients achieving ‘textbook’ outcomes is comparable with international standards. The identification of textbook parameters allows further focus for future quality improvement initiatives. Take-home message: National KPIs improve peri-operative outcomes in oesophago-gastric cancer.